首页> 外文期刊>The Breast : >The correlation between type endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: a systematic review and meta-analysis of randomized and non-randomized trials

【24h】

The correlation between type endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: a systematic review and meta-analysis of randomized and non-randomized trials

机译：激素敏感晚期乳腺癌患者患者患者内分泌治疗与雌激素受体-1突变的相关性：随机和非随机试验的系统回顾和荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast :》 |2019年第1期|共1页
作者
Najim O.;
展开▼
作者单位

Univ Hosp Antwerp Breast Clin Brussels Belgium;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学;
关键词

相似文献

外文文献
中文文献
专利

1. The correlation between type endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: a systematic review and meta-analysis of randomized and non-randomized trials [J] . Najim O. The Breast : . 2019,第Suppla1期

机译：激素敏感晚期乳腺癌患者患者患者内分泌治疗与雌激素受体-1突变的相关性：随机和非随机试验的系统回顾和荟萃分析
2. The correlation between type endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: a systematic review and meta-analysis of randomized and non-randomized trials [J] . Najim O. The Breast : . 2019,第期

机译：激素敏感晚期乳腺癌患者患者患者内分泌治疗与雌激素受体-1突变的相关性：随机和非随机试验的系统回顾和荟萃分析
3. The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials [J] . Najim Omar, Seghers Sofie, Sergoynne Laurine, Biochimica et biophysica acta. Reviews on cancer . 2019,第2期

机译：激素敏感晚期乳腺癌患者内分泌治疗类型与雌激素受体-1突变的关系：随机和非随机试验的系统评论和荟萃分析
4. A Single Tube Screening of Endocrine Therapy Resistance ESR1 Mutations in ER-Positive Breast Cancer [C] . Akihiro Tsuyada, Shunsuke Nakano, Toshimitsu Ichijo, International Molecular Medicine Tri-Conference. . 2016

机译：ER阳性乳腺癌内分泌治疗抗ESR1突变的单管筛选
5. The Role of Reproductive Risk Factors in Hereditary Breast Cancer Within BRCA Mutation Carriers: Systematic Review and Meta-Analysis [D] . Springer, Tamara. 2021

机译：BRCA突变载体中生殖危险因素在遗传性乳腺癌中的作用：系统评价和荟萃分析
6. Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive HER2 negative advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials [O] . Claudia Omarini, Federico Piacentini, Isabella Sperduti, 2020

机译：对于激素受体阳性HER2阴性晚期乳腺癌的老年患者联合内分泌疗法与单独内分泌疗法作为一线治疗：是为患者还是医生开药？ II和III期随机临床试验的荟萃分析
7. Efficacy and Safety of Aidi Injection as an Adjuvant Therapy on Advanced Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [O] . Yihui Chai, Yunzhi Chen, Wen Li, 2020

机译：AIDI注射作为晚期乳腺癌辅助治疗的疗效和安全性：随机对照试验的系统评价和荟萃分析
8. Systematic Reviews of Randomized Controlled Trials of Chemotherapy and Endocrine Therapy in Advanced Breast Cancer [R] . Simes, J. 2000

机译：系统评价晚期乳腺癌化疗和内分泌治疗的随机对照试验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号